138 related articles for article (PubMed ID: 9185712)
21. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
22. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
23. Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases.
Cheng HJ; Flanagan JG
Cell; 1994 Oct; 79(1):157-68. PubMed ID: 7522971
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine kinases in malignant melanoma.
Easty DJ; Bennett DC
Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
[TBL] [Abstract][Full Text] [Related]
25. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
[TBL] [Abstract][Full Text] [Related]
26. Organization of the human PTK7 gene encoding a receptor protein tyrosine kinase-like molecule and alternative splicing of its mRNA.
Jung JW; Ji AR; Lee J; Kim UJ; Lee ST
Biochim Biophys Acta; 2002 Dec; 1579(2-3):153-63. PubMed ID: 12427550
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG.
Park SK; Lee HS; Lee ST
J Biochem; 1996 Feb; 119(2):235-9. PubMed ID: 8882711
[TBL] [Abstract][Full Text] [Related]
28. Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain.
Xu Q; Alldus G; Holder N; Wilkinson DG
Development; 1995 Dec; 121(12):4005-16. PubMed ID: 8575301
[TBL] [Abstract][Full Text] [Related]
29. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.
Funasaka Y; Boulton T; Cobb M; Yarden Y; Fan B; Lyman SD; Williams DE; Anderson DM; Zakut R; Mishima Y
Mol Biol Cell; 1992 Feb; 3(2):197-209. PubMed ID: 1372524
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.
Kim JH; Kwon J; Lee HW; Kang MC; Yoon HJ; Lee ST; Park JH
Oncol Rep; 2014 Jun; 31(6):2708-12. PubMed ID: 24789704
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Yang P; Becker D
Int J Oncol; 2000 Nov; 17(5):913-9. PubMed ID: 11029492
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
33. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of the full-length mouse Ptk7 cDNA encoding a defective receptor protein tyrosine kinase.
Jung JW; Shin WS; Song J; Lee ST
Gene; 2004 Mar; 328():75-84. PubMed ID: 15019986
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
Wang Y; Becker D
Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
[TBL] [Abstract][Full Text] [Related]
36. cDNA-array profiling of melanomas and paired melanocyte cultures.
Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
[TBL] [Abstract][Full Text] [Related]
37. Microarray analysis of phosphatase gene expression in human melanoma.
McArdle L; Rafferty MM; Satyamoorthy K; Maelandsmo GM; Dervan PA; Herlyn M; Easty DJ
Br J Dermatol; 2005 May; 152(5):925-30. PubMed ID: 15888148
[TBL] [Abstract][Full Text] [Related]
38. Protein kinases in normal and transformed melanocytes.
Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
[TBL] [Abstract][Full Text] [Related]
39. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization.
Boukerche H; Su ZZ; Kang DC; Fisher PB
Gene; 2004 Dec; 343(1):191-201. PubMed ID: 15563845
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphate in melanoma progression.
McArdle L; Bergin O; Fallowfield ME; Dervan PA; Easty DJ
Br J Dermatol; 2003 Aug; 149(2):289-95. PubMed ID: 12932234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
